Upstream Bio Inc
Upstream Bio Inc (UPB) Covered Calls
No qualifying covered call setups were found for UPB in the prior session.
Read more
Running UPB covered calls helps you generate consistent income from Upstream Bio Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Upstream Bio Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best UPB covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if UPB stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling UPB covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Upstream Bio Inc covered call is worth writing.
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.
Income-focused investors, long-term UPB holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling UPB covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Upstream Bio Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile61.51% Neutral
- Market cap (M$)294
- 52 weeks high-84.09%
- 52 weeks low7.41%
- Analyst recommendationStrong Buy
1.50 - Target price$29.83
456.53% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E—
- EPS (ttm)-2.89
- EPS growth next 5 years-2.72%
As of September 25, 2026
No illustrative rows to display.
As of September 25, 2026
Sell covered calls with the data behind you
Find the best UPB covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→